🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To investigate the relative bioavailability of BI 10773 following coadminis...
Status
Completed
Location
1245.58.1 Boehringer Ingelheim Investigational Site
Start Date
2011-02
Trial ID
NCT01301742
Treatments Being Tested
This study is being done to look at how tucatinib could affect the way othe...
Status
Completed
Location
Covance Clinical Research Unit
Start Date
2018-09-17
Trial ID
NCT03723395
Treatments Being Tested
The purpose of this study is to evaluate the effects of multiple doses of G...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2009-09
Trial ID
NCT00966966
Treatments Being Tested
The purpose of this study is to evaluate the pharmacokinetics (PK), drug-dr...
Status
Completed
Location
MAC Clinical Research
Start Date
2024-05-02
Trial ID
NCT06392659
Treatments Being Tested
This was a double-blind randomized trial comparing 1200 mg per day of gemfi...
Status
Completed
Location
Minneapolis VA Health Care System, Minneapolis, MN
Start Date
1991-06
Trial ID
NCT00283335
Treatments Being Tested
The purpose of this study is to assess the effect of multiple doses of itra...
Status
Completed
Location
Multiple Locations
Start Date
2014-09
Trial ID
NCT02230033
Treatments Being Tested
Prostate cancer is the most common malignancy amongst men in United States....
Status
Withdrawn
Location
Saint Louis Univeristy
Start Date
2021-12-01
Trial ID
NCT04995978
Treatments Being Tested
This study will assess the potential for clinical drug-drug interactions be...
Status
Completed
Location
Covance Clinical Research Unit (CRU) Inc.
Start Date
2019-06-14
Trial ID
NCT04008186
The purpose of this study is to determine whether two oral formulations of ...
Status
Completed
Location
Multiple Locations
Start Date
2005-07
Trial ID
NCT00800475
Treatments Being Tested
This is a phase 1, 2-part, open-label, fixed-sequence study evaluating pote...
Status
Completed
Location
GSK Investigational Site
Start Date
2023-07-26
Trial ID
NCT05959447
Treatments Being Tested